Total Valuation
NeoPharm Co., Ltd. has a market cap or net worth of ₩352.71B. The enterprise value is ₩141.49K.
Market Cap₩352.71B
Enterprise Value₩141.49K
Share Statistics
NeoPharm Co., Ltd. has 16,027,988 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,027,988
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NeoPharm Co., Ltd.’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 12.39%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)12.39%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee937.48M
Profits Per Employee197.33M
Employee Count141
Asset Turnover0.60
Inventory Turnover3.05
Valuation Ratios
The current PE Ratio of NeoPharm Co., Ltd. is 6.1. NeoPharm Co., Ltd.’s PEG ratio is 0.32.
PE Ratio6.1
PS Ratio1.38
PB Ratio0.93
Price to Fair Value0.93
Price to FCF6.70
Price to Operating Cash Flow7.26
PEG Ratio0.32
Income Statement
In the last 12 months, NeoPharm Co., Ltd. had revenue of 132.18B and earned 27.82B in profits. Earnings per share was 1.78K.
Revenue132.18B
Gross Profit84.71B
Operating Income28.77B
Pretax Income32.26B
Net Income27.82B
EBITDA31.88B
Earnings Per Share (EPS)1.78K
Cash Flow
In the last 12 months, operating cash flow was 24.68B and capital expenditures -1.21B, giving a free cash flow of 23.47B billion.
Operating Cash Flow24.68B
Free Cash Flow23.47B
Free Cash Flow per Share1.46K
Dividends & Yields
NeoPharm Co., Ltd. pays an annual dividend of ₩750, resulting in a dividend yield of ―
Dividend Per Share₩750
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.14
52-Week Price Change20.57%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)49.12K
Important Dates
NeoPharm Co., Ltd. upcoming earnings date is Nov 6, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 6, 2026
Ex-Dividend Date―
Financial Position
NeoPharm Co., Ltd. as a current ratio of 8.40, with Debt / Equity ratio of 0.86%
Current Ratio8.40
Quick Ratio7.65
Debt to Market Cap<0.01
Net Debt to EBITDA-0.78
Interest Coverage Ratio729.87
Taxes
In the past 12 months, NeoPharm Co., Ltd. has paid 4.44B in taxes.
Income Tax4.44B
Effective Tax Rate0.14
Enterprise Valuation
NeoPharm Co., Ltd. EV to EBITDA ratio is 4.94, with an EV/FCF ratio of 5.78.
EV to Sales1.19
EV to EBITDA4.94
EV to Free Cash Flow5.78
EV to Operating Cash Flow5.54
Balance Sheet
NeoPharm Co., Ltd. has ₩147.59B in cash and marketable securities with ₩1.65B in debt, giving a net cash position of ₩145.94B billion.
Cash & Marketable Securities₩147.59B
Total Debt₩1.65B
Net Cash₩145.94B
Net Cash Per Share₩9.11K
Tangible Book Value Per Share₩12.38K
Margins
Gross margin is 49.91%, with operating margin of 21.77%, and net profit margin of 21.05%.
Gross Margin49.91%
Operating Margin21.77%
Pretax Margin24.41%
Net Profit Margin21.05%
EBITDA Margin24.11%
EBIT Margin21.77%
Analyst Forecast
The average price target for NeoPharm Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast19.89%
EPS Growth Forecast21.27%